Abstract
Introduction
Acute pancreatitis is defined as inflammation of pancreas, with or without tissue fibrosis. 1 Biliary stone and alcohol are the most common cause of acute pancreatitis. 2 In this paper we report a case of acute pancreatitis following angiography, a rare cause.
Case Report
The patient was a 71 years old woman, presenting to our emergency department with acute, severe, continuous and positional epigastric pain, accompanied with nausea and non-bilious, nonbloody vomiting containing ingested food. There was no itching, icterus and anorexia. She was hospitalized in a cardiology center for chest pain, undergoing angiographic procedure about 48 hours before admission to our emergency department. Angiography was done by catheterization of femoral artery and injection of about 100 cc of Visipaque™ (GE Healthcare, Cork, Ireland). Coronary artery stenosis was ruled out and the patient was discharged with medical treatment.
The patient was under medical treatment with aspirin, allopurinol, metoprolol and spironolactone for several months before angiography and after that, without any significant adverse effect. On arrival, vital signs were stable and except severe epigastric tenderness nothing was detected. Lab test showed a high serum amylase level (more than 500 IU/l). Abdominal sonography reveals several hypoechoic zones in pancreas head and neck with surrounding edema. Pancreatic duct had normal size, common bile duct (CBD) was mildly dilated (10 mm), and no stone or mass was detected. Magnetic resonance cholangiopancreatography (MRCP) showed mild dilatation of CBD, pancreatic head enlargement and mild effusion in hepatorenal pouch (Figure 1 ). There were no signs of stone, sludge or mass in the biliary tract. Therefore, patient was admitted to the gastroenterology ward with the diagnosis of acute pancreatitis, received conservative treatment and was discharged with marked improvement after five days.
Discussion
Acute pancreatitis (inflammation of pancreas) has different etiologies which in order of frequency are biliary stones, alcohol, trauma, infection, hypotensive episodes, hypertriglyceridemia, hereditary and metabolic disturbance, etc. 3 New and rare etiologies of acute pancreatitis, which are truly affecting morbidity and mortality of patients, have been introduced recently. Drugs, intravenous radiocontrast agents (used during angiography or other imaging modalities), 4 peripheral vascular disease and atherosclerosis 5 are some of them.
In this patient angiography was suggested as the most probable cause due to its temporal relationship with the occurrence of acute pancreatitis and also the absence of other risk factors.
During angiography, both contrast media and cholesterol crystals embolization (atheroembolism) can be responsible for necrosis of pancreas. [5] [6] [7] [8] Several cases of pancreatitis due to contrast media consumption have been presented. 9,10 Recently Jin et al. reported that contrast media consumption leads to acute pancreatitis because of changing some cellular calcium signaling pathways. 11 Visipaque™ (iodixanol: C35H44I6N6O15, 100 cc) was the contrast agent used in this case. It is an isosmolar, water soluble and nonionic agent, with a molecular weight of 1550.20. Its iodine content is 49.1%. Occurrences of acute pancreatitis after Visipaque™ consumption is a novel finding, not reported in the past. On the other hand, presence and moving of cholesterol crystals through the blood vessels (atheroembolism) as the result of atherosclerotic vessel wall traumatization during angiography, is questionable, too. Since our patient did not have typical feature of atheroembolism such as blue toe or renal failure, and regarding to previous similar reports about necrotizing pancreatitis caused by contrast agents, it is assumed that contrast agent used during angiography was responsible for necrosis of pancreas in mentioned patient, not atheroembolism.
Pancreatitis is a known complication of angiography that occurs due to atheroembolism or contrast agents. There are a few documents about Visipaque™ and its inflammatory mechanism, too. There are not enough evidences to indicate whether using non-ionic or low osmolality contrast agent can prevent pancreatitis. 12 Well-designed clinical trials are needed to answer this question.
